Evidence map›Paper›PMID 22570610›Full record

ArticlePLoS pathogens2012

Evolutionary reconstructions of the transferrin receptor of Caniforms supports canine parvovirus being a re-emerged and not a novel pathogen in dogs.

Jason T Kaelber, Ann Demogines, Carole E Harbison, Andrew B Allison, Laura B Goodman, Alicia N Ortega, Sara L Sawyer, Colin R Parrish

Open access · goldAbstract read
In one paragraph

Article in PLoS pathogens, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 59 papers.

0numbers the graph read from it
0cells of the map it votes in
59citing papers in PubMed
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

59 citing papers in PubMed, 89 citations in OpenAlex.

  1. Article
  2. Article
  3. Extensive longevity and DNA virus-driven adaptation in nearcticbioRxiv : the preprint server for biology · 2025
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Review
  10. Old and Novel Enteric Parvoviruses of Dogs.Pathogens (Basel, Switzerland) · 2023
    Review
  11. The role of ferroptosis in virus infections.Frontiers in microbiology · 2023
    Review
  12. Article
  13. Article
  14. Review
  15. Article
  16. High-resolution asymmetric structure of a Fab-virus complex reveals overlap with the receptor binding site.Proceedings of the National Academy of Sciences of the United States of America · 2021
    Article
  17. Article
  18. Molecular Characteristics ofPathogens (Basel, Switzerland) · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Jason T KaelberBaker Institute for Animal Health, Department of Microbiology and Immunology, College of Veterinary Medicine, Cornell University, Ithaca, New York, United States of America.
Ann Demogines
Carole E Harbison
Andrew B Allison
Laura B Goodman
Alicia N Ortega
Sara L Sawyer
Colin R Parrish
Cornell University · USThe University of Texas at Austin · US

Funding

The Evolutionary and Biological Bases of Host Switching in VirusesR01GM080533 · NIGMS · PENNSYLVANIA STATE UNIVERSITY, THE · PI PARRISH, COLIN R. · 2007 to 2019
$4.1M
Structural Controls of Functional Receptor and Antibody Binding to Viral Capsids.R01AI092571 · NIAID · CORNELL UNIVERSITY · PI PARRISH, COLIN R. · 2011 to 2021
$4.0M
PARVOVIRUS STRUCTURE, FUNCTION AND HOST RANGER01AI028385 · NIAID · CORNELL UNIVERSITY ITHACA · PI PARRISH, COLIN R. · 1990 to 2011
$3.0M
PARVOVIRUS STRUCTURE, CAPSID ASSEMBLY, AND RECEPTORSR01AI033468 · NIAID · CORNELL UNIVERSITY ITHACA · PI PARRISH, COLIN R. · 1993 to 2007
$2.3M
Rapid evolution of genes critical for genome integrityR01GM093086 · NIGMS · UNIVERSITY OF TEXAS AT AUSTIN · PI SAWYER, SARA · 2010 to 2016
$1.9M
Engineering altered receptors and antibodies to study viral functionsF32AI082922 · NIAID · DANA-FARBER CANCER INST · PI GOODMAN, LAURA BRUNENGRABER · 2009 to 2010
$102k
NIAID NIH HHS F32 AI082922NIAID NIH HHS F32AI082922NIAID NIH HHS R01 AI028385NIAID NIH HHS R01 AI033468NIAID NIH HHS R01 AI092571NIAID NIH HHS R01 AI28385NIAID NIH HHS R01 AI33468NIGMS NIH HHS R01 GM080533NIGMS NIH HHS R01 GM093086NIGMS NIH HHS R01-GM-093086
6 · The paper itself

Abstract

Parvoviruses exploit transferrin receptor type-1 (TfR) for cellular entry in carnivores, and specific interactions are key to control of host range. We show that several key mutations acquired by TfR during the evolution of Caniforms (dogs and related species) modified the interactions with parvovirus capsids by reducing the level of binding. These data, along with signatures of positive selection in the TFRC gene, are consistent with an evolutionary arms race between the TfR of the Caniform clade and parvoviruses. As well as the modifications of amino acid sequence which modify binding, we found that a glycosylation site mutation in the TfR of dogs which provided resistance to the carnivore parvoviruses which were in circulation prior to about 1975 predates the speciation of coyotes and dogs. Because the closely-related black-backed jackal has a TfR similar to their common ancestor and lacks the glycosylation site, reconstructing this mutation into the jackal TfR shows the potency of that site in blocking binding and infection and explains the resistance of dogs until recent times. This alters our understanding of this well-known example of viral emergence by indicating that canine parvovirus emergence likely resulted from the re-adaptation of a parvovirus to the resistant receptor of a former host.

Indexed as

Amino Acid SequenceAnimalsBase SequenceBiological EvolutionCanidaeCapsidCapsid ProteinsCHO CellsCricetinaeDog DiseasesDogsGlycosylationHost-Pathogen InteractionsMutationParvoviridae InfectionsParvovirus, CanineCapsid ProteinsReceptors, TransferrinReceptors, VirusTransferrin

Identifiers

PMID22570610
PMCPMC3342950
OpenAlexW2020255337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.